Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders

NCT01832597

Conditions: Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: UO di Ematologia, S.O. Annunziata Cosenza, CZ, Italy

Dipartimento di Oncologia, Ematologia e Patologie dell'Apparato Respiratorio, Universita' di Modena e Reggio Emilia Modena, MO, Italy

UO di Ematologia, AOUP Paolo Giaccone, Palermo, PA, Italy

View Trial Details

Completed

Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma

NCT00440635

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

NCT00698243

Conditions: Any Solid Tumor or Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

University Hospitals Leuven Leuven, Belgium

Royal Mardsen Hospital Sutton, Surrey, United Kingdom

View Trial Details

Completed

Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

NCT00004162

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

View Trial Details

Completed

Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma

NCT01829412

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

NCT00002563

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations: Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States

Ellis Fischel Cancer Center - Columbia Columbia, Missouri, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

NCT00002552

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00002908

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

NCT00002907

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00003956

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions